A detailed history of Weybosset Research & Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Weybosset Research & Management LLC holds 650 shares of AMGN stock, worth $208,364. This represents 0.08% of its overall portfolio holdings.

Number of Shares
650
Holding current value
$208,364
% of portfolio
0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $170,787 - $207,551
650 New
650 $203,000
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $178,990 - $201,922
700 New
700 $201,000
Q4 2022

Feb 16, 2023

SELL
$229.03 - $291.01 $91,612 - $116,404
-400 Reduced 21.62%
1,450 $381,000
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $89,784 - $101,260
400 Added 27.59%
1,850 $417,000
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $80,748 - $89,859
-350 Reduced 19.44%
1,450 $353,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $34,804 - $39,830
175 Added 10.77%
1,800 $405,000
Q3 2021

Oct 25, 2021

BUY
$212.27 - $248.7 $15,920 - $18,652
75 Added 4.84%
1,625 $346,000
Q2 2021

Jul 26, 2021

SELL
$233.58 - $259.14 $5,839 - $6,478
-25 Reduced 1.59%
1,550 $378,000
Q4 2020

Jan 21, 2021

SELL
$216.38 - $257.67 $32,457 - $38,650
-150 Reduced 8.7%
1,575 $362,000
Q1 2020

Apr 13, 2020

SELL
$182.24 - $241.7 $27,336 - $36,255
-150 Reduced 8.0%
1,725 $343,000
Q4 2019

Jan 27, 2020

BUY
$189.21 - $243.2 $354,768 - $456,000
1,875 New
1,875 $452,000
Q3 2019

Oct 22, 2019

SELL
$174.11 - $208.62 $326,456 - $391,162
-1,875 Closed
0 $0
Q1 2019

Apr 15, 2019

BUY
$180.87 - $203.88 $36,174 - $40,776
200 Added 11.94%
1,875 $356,000
Q4 2018

Jan 25, 2019

SELL
$178.4 - $208.25 $8,920 - $10,412
-50 Reduced 2.9%
1,675 $326,000
Q3 2018

Oct 11, 2018

BUY
$185.29 - $208.89 $13,896 - $15,666
75 Added 4.55%
1,725 $358,000
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $278,503 - $311,173
1,650
1,650 $287,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Weybosset Research & Management LLC Portfolio

Follow Weybosset Research & Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weybosset Research & Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weybosset Research & Management LLC with notifications on news.